Search

Search Constraints

You searched for: Author/Creator Thalme, Anders

Search Results

1. Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 96-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study. Issue 11 (November 2021)

3. Microbial translocation revisited: targeting the endotoxic potential of gut microbes in HIV-infected individuals. (15th March 2019)

5. Reduced Levels of D-dimer and Changes in Gut Microbiota Composition After Probiotic Intervention in HIV-Infected Individuals on Stable ART. (1st December 2015)

7. Switching from tenofovir disoproxil fumarate to tenofovir alafenamide coformulated with rilpivirine and emtricitabine in virally suppressed adults with HIV-1 infection: a randomised, double-blind, multicentre, phase 3b, non-inferiority study. Issue 5 (May 2017)